This is just the kind of PR mess that commissioner Bud Selig and his cronies didn’t need this month.
The National League’s newly minted Most Valuable Player tested positive for enhanced testosterone levels during the postseason, and now Ryan Braun joins legends like Barry Bonds, Roger Clemens, Alex Rodriguez and Mark McGwire in being implicated for steroid usage.
Through his own PR guy, Braun maintained his innocence, and there’s a chance his name will be cleared on appeal. Still, the steroid taint never goes away entirely.
It’s a real shame, in part because Braun seemed a bit more human than some of the league’s recent heroes. At 6-foot-1 and 210 pounds, he looks normal enough, yet he hits some of the hardest balls of anyone in the league. Braun also has a rep as a good guy, and he committed himself to spending the bulk of his career with the small-market Brewers when he signed a $105 million extension through 2020 in April.
So, if a guy like Braun, who has next to nothing left to gain financially by roiding, is cheating anyway, it suggests baseball’s steroid problem isn’t even close to being wiped out. That baseball gets the bulk of the attention in this department even though steroids have certainly been more prevalent during the NFL’s history isn’t fair, but it’s the game’s burden anyway.
The Brewers reportedly signed third baseman Mike Moustakas to a one-year, $10 million contract on Sunday. While the deal is not yet official, MLB.com’s Adam McCalvy reports that the Brewers plan to give Moustakas a look at second base during spring training. If all goes well, he will be the primary second baseman and Travis Shaw will stay at third base.
The initial thought was that Moustakas would simply take over at third base for the more versatile Shaw. Moustakas has spent 8,035 of his career defensive innings at third base, 35 innings at first base, and none at second. In fact, he has never played second base as a pro player. Shaw, meanwhile, has spent 268 of his 4,073 1/3 defensive innings in the majors at second base and played there as recently as October.
This is certainly an interesting wrinkle to signing Moustakas, who is a decent third baseman. He was victimized by another slow free agent market, not signing until March last year on a $6.5 million deal with a $15 million mutual option for this season. That option was declined, obviously, and he ended up signing for $5 million cheaper here in February as the Brewers waited him out. Notably, Moustakas did not have qualifying offer compensation attached to him this time around.
Last season, between the Royals and Brewers, the 30-year-old Moustakas hit .251/.315/.459 with 28 home runs and 95 RBI in 635 plate appearances.